Agilon Health (NYSE:AGL) Reaches New 12-Month Low – Should You Sell?

Agilon Health, Inc. (NYSE:AGL) shares hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $7.48 and last traded at $8.18, with a volume of 44516 shares changing hands. The stock had previously closed at $8.0350.

Analysts Set New Price Targets

A number of research firms recently weighed in on AGL. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research note on Wednesday, January 21st. Wells Fargo & Company lifted their price target on shares of Agilon Health from $25.00 to $37.50 and gave the stock an “overweight” rating in a research note on Friday, February 27th. Barclays lowered their price target on shares of Agilon Health from $25.00 to $12.50 and set an “underweight” rating for the company in a report on Friday, February 27th. BTIG Research reissued a “neutral” rating on shares of Agilon Health in a research report on Friday, December 12th. Finally, Citigroup decreased their price objective on shares of Agilon Health from $21.25 to $18.75 and set a “neutral” rating for the company in a research report on Tuesday, March 3rd. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $54.38.

Agilon Health Stock Performance

The company has a market cap of $161.75 million, a PE ratio of -0.41 and a beta of 0.33. The stock has a 50 day simple moving average of $14.26 and a two-hundred day simple moving average of $18.59. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, February 25th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.19). Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%.The business had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.46 billion. Equities analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current year.

Institutional Investors Weigh In On Agilon Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Wealthcare Advisory Partners LLC purchased a new position in shares of Agilon Health during the third quarter worth about $26,000. LPL Financial LLC increased its position in Agilon Health by 213.4% in the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares during the period. Krilogy Financial LLC purchased a new stake in Agilon Health during the 4th quarter valued at approximately $34,000. CIBC Bancorp USA Inc. acquired a new stake in Agilon Health during the 3rd quarter worth approximately $34,000. Finally, Merit Financial Group LLC acquired a new stake in Agilon Health during the 4th quarter worth approximately $35,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.